Search

everythinglearnresearchcommunity

for

Search:↓

New findings suggest targeting IL-23 could treat psoriasis, skin cells can adapt to new roles, direct conversion of skin cells to blood cells may aid cell therapy, removing certain tumor cells could boost cancer immunotherapy, and melanoma may have many tumorigenic cells, not just cancer stem cells.

Topical immunotherapy for alopecia areata may work by creating immune cell clusters in the skin.

iNKT cells help develop and maintain healthy skin in young mice.

IL-15 promotes hair growth and protects hair follicles.

Interleukin levels are higher in alopecia areata patients but don't predict disease severity or duration.

Hair follicles could help develop eye treatments by studying immune responses.

Alopecia areata patients show unique protein activity patterns, suggesting imbalanced signaling pathways.

Wnt-signaling is regulated differently in skin cells and immune responses during wound healing.

IL-15 helps protect hair follicles from immune attacks and encourages hair growth.

Autoimmune thyroid disease raises the risk of many health issues but lowers the risk of lung cancer and allergic rhinitis.

Expanding CD4+ Tregs can stop hair loss in alopecia areata.

A rare case of a transplant patient developing a skin condition linked to HPV-49.

Targeting specific biomarkers and immune signals is more effective and safer for treating inflammatory skin diseases.

Psoriasis is linked to a higher risk of autoimmune diseases and other health conditions.

BST2 is highly expressed in certain immune cells in alopecia areata, suggesting a role in the disease.

A child's rare skin disease was triggered by chickenpox.

Type 2 cytokines IL-4 and IL-13 increase skin's vulnerability to Staphylococcus aureus, which could be important for treating atopic dermatitis.

Increasing Treg cells in the skin does not cure hair loss from alopecia areata in mice.

Hair follicles regulate immune cells in the skin, and disrupting certain pathways can lead to skin issues and infections.

Developing human skin has immune cells with memory-like features.

Intensive immunosuppression can reduce relapse rates in multiple sclerosis patients, despite some side effects.

A gene mutation in mice causes increased mast cells and disorganized hair follicles in their skin.

Anti-Desmocollin 3 antibodies can cause atypical pemphigus symptoms.

Skin-resident memory T cells may contribute to chronic alopecia areata and baricitinib could be a potential treatment.

Newborns with the common rash Erythema Toxicum have many active mast cells in their skin, but these cells don't produce the LL-37 peptide.

Live vaccines can be safely given to infants with a FOXN1 variant if their immune function improves over time.

IBD patients treated with TNF antagonists may develop autoimmune alopecia areata, with severe cases less likely to improve.